Document Type : Original Article
Authors
1 Medical Division, Sahajanand Laser Technology Limited, A-8, G.I.D.C, Electronic Estate, Sec-25, Gandhinagar 382028, India
2 Sahajanand Laser Technology Limited, A-8, G.I.D.C, Electronic Estate, Sec-25, Gandhinagar 382028, India
3 Interventional Cardiologist, Maharaja Agrasen Hospital, Fulbari Truck Terminus, Dist, Siliguri, West Bengal 734015, India
4 Interventional Cardiologist, North Bengal Neuro Centre Multispeciality Hospital, Maghnad Saha Sarani, Ward 2, Pradhan Nagar, Siliguri, West Bengal, 734003, India
Abstract
BACKGROUND: The present post-marketing clinical study was conducted over a 12-month follow-up period to monitor the clinical outcomes of patients treated with the Vector® Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter for the dilatation of coronary lesions. The semi-compliant balloon improves balloon-to-vessel wall apposition and minimizes balloon slippage during PTCA, which could reduce complications and improve clinical outcomes. This investigation aimed to assess the safety and effectiveness of the Vector® PTCA Balloon Catheter in real-world settings.
METHODS: A retrospective study was conducted to investigate the safety and efficacy of the Vector® PTCA Balloon Catheter in 125 patients who underwent pre-dilatation and post-dilatation. The primary outcome of the study was major adverse cardiac events (MACE), a composite endpoint encompassing target-lesion revascularization (TLR), cardiac death, and myocardial infarction (MI).
RESULTS: The Vector® PTCA Balloon Catheter has shown promising results in a small group of patients undergoing dilatation of normal and intricate coronary artery lesions, reflecting a 100% procedural success rate. The successful delivery to the target lesion, deployment, and subsequent retrieval of the device during the index procedure led to a 100% device success rate without any technical issues. A total of 3.2% (4) patients experienced MACE during the 12-month follow-up, with 1.6% (2) MI, 1.6% (2) TLR, and no cardiovascular deaths..
CONCLUSION: This study demonstrated the favorable safety and reliability of the Vector® PTCA Balloon Catheter in patients with angina, MI, and a history of coronary artery disease in a real-world setting.
Keywords
2. Engelen SE, Robinson AJB, Zurke YX, Monaco C. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat Rev Cardiol. 2022 Aug;19(8):522-42. https://doi.org/10.1038/s41569-021-00668-4
3. Boucher P, Matz RL, Terrand J. atherosclerosis: gone with the Wnt? Atherosclerosis. 2020 May;301:15-22. https://doi.org/10.1016/j.atherosclerosis.2020.03.024
4. McAloon CJ, Osman F, Glennon P, Lim PB, Hayat SA. Global epidemiology and incidence of cardiovascular disease. Cardiovasc Dis. 2016;57-96. https://doi.org/10.1016/B978-0-12-803312-8.00004-5
5. Ruan Y, Guo Y, Zheng Y, Huang Z, Sun S, Kowal P, et al. Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: results from SAGE Wave 1. BMC Public Health. 2018 Jun 20;18(1):778. https://doi.org/10.1186/s12889-018-5653-9
6. A Alhabib KF, Batais MA, Almigbal TH, Alshamiri MQ, Altaradi H, Rangarajan S, et al. Demographic, behavioral, and cardiovascular disease risk factors in the Saudi population: results from the Prospective Urban Rural Epidemiology study (PURE-Saudi). BMC Public Health. 2020 Aug 8;20(1):1213. https://doi.org/10.1186/s12889-020-09298-w
7. Tajabadi M, Goran Orimi H, Ramzgouyan MR, Nemati A, Deravi N, Beheshtizadeh N, et al. Regenerative strategies for the consequences of myocardial infarction: Chronological indication and upcoming visions. Biomed Pharmacother. 2022 Feb;146:112584. https://doi.org/10.1016/j.biopha.2021.112584
8. Novak K, Vrdoljak D, Jelaska I, Borovac JA. Sex-specific differences in risk factors for in-hospital mortality and complications in patients with acute coronary syndromes: An observational cohort study. Wien Klin Wochenschr. 2017 Apr;129(7-8):233-42. https://doi.org/10.1007/s00508-016-1105-7
9. Dai X, Busby-Whitehead J, Alexander KP. Acute coronary syndrome in the older adults. J Geriatr Cardiol. 2016 Feb;13(2):101-8. https://doi.org/10.11909/j.issn.1671-5411.2016.02.012
10. Faroux L, Campelo-Parada F, Munoz-Garcia E, Nombela-Franco L, Fischer Q, Donaint P, et al. Procedural Characteristics and Late Outcomes of Percutaneous Coronary Intervention in the Workup Pre-TAVR. JACC Cardiovasc Interv. 2020 Nov 23;13(22):2601-13. https://doi.org/10.1016/j.jcin.2020.07.009
11. Redfors B, Kosmidou I, Crowley A, Maehara A, Ben-Yehuda O, Arif A, et al. Prognostic significance of QRS fragmentation and correlation with infarct size in patients with anterior ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: Insights from the INFUSE-AMI trial. Int J Cardiol. 2018 Feb 15;253:20-24. https://doi.org/10.1016/j.ijcard.2017.10.051
12. Doll JA, Hira RS, Kearney KE, Kandzari DE, Riley RF, Marso SP, et al. Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference. Circ Cardiovasc Interv. 2020 Jun;13(6):e008962. https://doi.org/10.1161/circinterventions.120.008962
13. Lee KY, Chen DY, Hsu HL, Chen CJ, Tseng YC. Undersized angioplasty and stenting of symptomatic intracranial tight stenosis with Enterprise: Evaluation of clinical and vascular outcome. Interv Neuroradiol. 2016 Apr;22(2):187-95. https://doi.org/10.1177/1591019915609165
14. Majeed H, Chowdhury YS. Percutaneous transluminal angioplasty and balloon catheters. 2020.
15. Pradhan A, Vishwakarma P, Bhandari M, Sethi R, Chandra S, Chaudhary G, et al. Clinical Outcomes of a Non-Compliant Balloon Dilatation Catheter: MOZEC™ NC Study. Int J Environ Res Public Health. 2022 Dec 4;19(23):16231. https://doi.org/10.3390/ijerph192316231
16. Dini CS, Tomberli B, Mattesini A, Ristalli F, Valente S, Stolcova M, et al. Intravascular lithotripsy for calcific coronary and peripheral artery stenoses. EuroIntervention. 2019 Oct 20;15(8):714-21. https://doi.org/10.4244/eij-d-18-01056
17. Ali ZA, Nef H, Escaned J, Werner N, Banning AP, Hill JM, et al. Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: The Disrupt CAD II Study. Circ Cardiovasc Interv. 2019 Oct;12(10):e008434. https://doi.org/10.1161/circinterventions.119.008434
18. Sorini Dini C, Nardi G, Ristalli F, Mattesini A, Hamiti B, Di Mario C. Contemporary Approach to Heavily Calcified Coronary Lesions. Interv Cardiol. 2019 Nov 18;14(3):154-63. https://doi.org/10.15420/icr.2019.19.R1
19. Cortese B, di Palma G, Latini RA, Elwany M, Orrego PS, Seregni RG. Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry. Cardiovasc Revasc Med. 2017 Oct-Nov;18(7):487-91. https://doi.org/10.1016/j.carrev.2017.03.025
20. Costa RA, Mandal SC, Hazra PK, Chopda M, Chandra P, Damiani LP, et al. Sirolimus-Coated Balloon With a Microsphere-Based Technology for the Treatment of De Novo or Restenotic Coronary Lesions. Cardiovasc Revasc Med. 2022 Dec;45:18-25. https://doi.org/10.1016/j.carrev.2022.08.037
21. Basavarajaiah S, Athukorala S, Kalogeras K, Panoulas V, Loku Waduge BH, Bhatia G, et al. Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population. Catheter Cardiovasc Interv. 2021 Jul 1;98(1):57-65. https://doi.org/10.1002/ccd.28998
22. Yamashita Y, Shiomi H, Morimoto T, Yaku H, Furukawa Y, Nakagawa Y, et al. Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1):e002790. https://doi.org/10.1161/circoutcomes.116.002790
23. Fathima SN. An Update on Myocardial Infarction. Current Research and Trends in Medical Science and Technology. 2021;1.
24. Parasca CA, Head SJ, Milojevic M, Mack MJ, Serruys PW, Morice MC, et al. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years. JACC Cardiovasc Interv. 2016 Dec 26;9(24):2493-507. https://doi.org/10.1016/j.jcin.2016.09.044
25. Konigstein M, Redfors B, Zhang Z, Kotinkaduwa LN, Mintz GS, Smits PC, et al. Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials. J Am Heart Assoc. 2022 Dec 20;11(24):e025275. https://doi.org/10.1161/jaha.121.025275
26. Mach M, Szalkiewicz P, Poschner T, Hasan W, Andreas M, Winkler B, et al. The use of semi-compliant versus non-compliant balloon systems for predilatation during the implantation of self-expandable transcatheter aortic valves: Data from the VIenna CardioThOracic Aortic Valve RegistrY (VICTORY). Eur J Clin Invest. 2021 Sep;51(9):e13570.
27. Kitani S, Igarashi Y, Tsuchikane E, Nakamura S, Seino Y, Habara M, et al. Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry). Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E614-E23. https://doi.org/10.1002/ccd.29185
28. Lu W, Zhu Y, Han Z, Sun G, Qin X, Wang Z, et al. Short-term outcomes from drug-coated balloon for coronary de novo lesions in large vessels. J Cardiol. 2019 Feb;73(2):151-5. https://doi.org/10.1016/j.jjcc.2018.07.008
29. Cuculi F, Bossard M, Zasada W, Moccetti F, Voskuil M, Wolfrum M, et al. Performing percutaneous coronary interventions with predilatation using non-compliant balloons at high-pressure versus conventional semi-compliant balloons: insights from two randomised studies using optical coherence tomography. Open Heart. 2020 Jan 23;7(1):e001204. https://doi.org/10.1136/openhrt-2019-001204
)